Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 5
2018 3
2019 6
2020 3
2021 5
2022 12
2023 13
2024 8
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Combination Immunotherapy in Prostate Cancer.
Baxevanis CN, Goulielmaki M, Gritzapis AD, Fortis SP. Baxevanis CN, et al. Among authors: fortis sp. Cancers (Basel). 2022 Dec 8;14(24):6040. doi: 10.3390/cancers14246040. Cancers (Basel). 2022. PMID: 36551526 Free PMC article.
Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines.
Tsantes AG, Petrou E, Tsante KA, Sokou R, Frantzeskaki F, Domouchtsidou A, Chaldoupis AE, Fortis SP, Piovani D, Nikolopoulos GK, Iacovidou N, Bonovas S, Samonis G, Tsantes AE. Tsantes AG, et al. Among authors: fortis sp. Cancers (Basel). 2024 May 30;16(11):2082. doi: 10.3390/cancers16112082. Cancers (Basel). 2024. PMID: 38893201 Free PMC article. Review.
Radiotherapy-Related Gene Signature in Prostate Cancer.
Fortis SP, Goulielmaki M, Aubert N, Batsaki P, Ouzounis S, Cavouras D, Marodon G, Stokidis S, Gritzapis AD, Baxevanis CN. Fortis SP, et al. Cancers (Basel). 2022 Oct 14;14(20):5032. doi: 10.3390/cancers14205032. Cancers (Basel). 2022. PMID: 36291815 Free PMC article.
Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients.
Xagara A, Goulielmaki M, Fortis SP, Kokkalis A, Chantzara E, Christodoulopoulos G, Samaras I, Saloustros E, Tsapakidis K, Papadopoulos V, Pateras IS, Georgoulias V, Baxevanis CN, Kotsakis A. Xagara A, et al. Among authors: fortis sp. Cancers (Basel). 2024 Jun 28;16(13):2393. doi: 10.3390/cancers16132393. Cancers (Basel). 2024. PMID: 39001455 Free PMC article.
Blood Cell-Derived Microvesicles in Hematological Diseases and beyond.
Georgatzakou HT, Fortis SP, Papageorgiou EG, Antonelou MH, Kriebardis AG. Georgatzakou HT, et al. Among authors: fortis sp. Biomolecules. 2022 Jun 8;12(6):803. doi: 10.3390/biom12060803. Biomolecules. 2022. PMID: 35740926 Free PMC article. Review.
A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment.
Trifylli EM, Kriebardis AG, Koustas E, Papadopoulos N, Fortis SP, Tzounakas VL, Anastasiadi AT, Sarantis P, Vasileiadi S, Tsagarakis A, Aloizos G, Manolakopoulos S, Deutsch M. Trifylli EM, et al. Among authors: fortis sp. Int J Mol Sci. 2024 Mar 17;25(6):3406. doi: 10.3390/ijms25063406. Int J Mol Sci. 2024. PMID: 38542378 Free PMC article. Review.
50 results